• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Administration of high-dose recombinant interleukin 2 after autologous bone marrow transplantation in patients with neuroblastoma: toxicity, efficacy and survival. A Lyon-Marseille-Curie-east of France Group Study.

作者信息

Michon J, Négrier S, Coze C, Mathiot C, Frappaz D, Oskam R, Pacquement H, Quintana E, Bouffet E, Bernard J L

机构信息

Biotherapy Unit, Institut Curie, Paris, France.

出版信息

Prog Clin Biol Res. 1994;385:293-300.

PMID:7972223
Abstract
摘要

相似文献

1
Administration of high-dose recombinant interleukin 2 after autologous bone marrow transplantation in patients with neuroblastoma: toxicity, efficacy and survival. A Lyon-Marseille-Curie-east of France Group Study.神经母细胞瘤患者自体骨髓移植后大剂量重组白细胞介素-2的应用：毒性、疗效和生存率。法国东部里昂-马赛-居里集团研究。
Prog Clin Biol Res. 1994;385:293-300.
2
Phase I-II study of interleukin-2 after high-dose chemotherapy and autologous bone marrow transplantation in poorly responding neuroblastoma.高剂量化疗及自体骨髓移植后白细胞介素-2用于低反应性神经母细胞瘤的I-II期研究
Bone Marrow Transplant. 1995 Oct;16(4):515-20.
3
Transplantation of patients with high risk acute myeloid leukemia in first remission with autologous marrow cultured in interleukin-2 followed by interleukin-2 administration.
Bone Marrow Transplant. 1994 Sep;14(3):389-96.
4
Progression of natural immunity during one-year treatment of residual disease in neuroblastoma patients with high doses of interleukin-2 after autologous bone marrow transplantation.自体骨髓移植后大剂量白细胞介素-2治疗神经母细胞瘤残留病一年期间自然免疫的进展
Exp Hematol. 1995 Dec;23(14):1445-52.
5
Interleukin 2 immunotherapy in children with neuroblastoma after high-dose chemotherapy and autologous bone marrow transplantation.大剂量化疗和自体骨髓移植后神经母细胞瘤患儿的白细胞介素2免疫疗法
Pediatr Hematol Oncol. 1990;7(3):275-84. doi: 10.3109/08880019009033403.
6
High-dose systemic interleukin-2 therapy in stage IV neuroblastoma for one year after autologous bone marrow transplantation: pilot study.自体骨髓移植后，大剂量全身白细胞介素-2治疗IV期神经母细胞瘤一年：初步研究
Med Pediatr Oncol. 1996 Dec;27(6):534-9. doi: 10.1002/(SICI)1096-911X(199612)27:6<534::AID-MPO5>3.0.CO;2-M.
7
A study of thiotepa, etoposide and fractionated total body irradiation as a preparative regimen prior to bone marrow transplantation for poor prognosis patients with neuroblastoma.一项关于硫替派、依托泊苷及分次全身照射作为预后不良神经母细胞瘤患者骨髓移植前预处理方案的研究。
Bone Marrow Transplant. 1996 Jun;17(6):911-6.
8
Phase I study of high-dose continuous intravenous infusion of VP-16 in combination with high-dose melphalan followed by autologous bone marrow transplantation in children with stage IV neuroblastoma.IV期神经母细胞瘤患儿大剂量VP - 16持续静脉输注联合大剂量美法仑后行自体骨髓移植的I期研究
Bone Marrow Transplant. 1996 Apr;17(4):485-9.
9
Randomized study of recombinant interleukin-2 after autologous bone marrow transplantation for acute leukemia in first complete remission.自体骨髓移植后重组白细胞介素-2用于首次完全缓解的急性白血病的随机研究。
Eur Cytokine Netw. 2000 Mar;11(1):91-8.
10
Efficacy and safety of inhaled recombinant interleukin-2 in high-risk renal cell cancer patients compared with systemic interleukin-2: an outcome study.与全身应用白细胞介素-2相比，吸入重组白细胞介素-2在高危肾细胞癌患者中的疗效和安全性：一项结果研究。
Folia Biol (Praha). 2003;49(5):183-90.